Company intelligence / Profile preview

Cryopharm

California, United Statescryopharm.com ↗
Ownership
Private
Employees
~3
Development stage
Other
01

Overview

Cryopharm's proprietary process dramatically enhances sublingual absorption, lowering response times in the body by bypassing hepatic metabolism[5]

Therapeutic areas
Psychiatry
Modalities
Sublingual delivery system
Industry
Non-Drug Biotech

Beyond the preview

Go deeper on Cryopharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cryopharm.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call